PGRC2_HUMAN - dbPTM
PGRC2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PGRC2_HUMAN
UniProt AC O15173
Protein Name Membrane-associated progesterone receptor component 2
Gene Name PGRMC2
Organism Homo sapiens (Human).
Sequence Length 223
Subcellular Localization Membrane
Single-pass membrane protein .
Protein Description Receptor for steroids..
Protein Sequence MAAGDGDVKLGTLGSGSESSNDGGSESPGDAGAAAEGGGWAAAALALLTGGGEMLLNVALVALVLLGAYRLWVRWGRRGLGAGAGAGEESPATSLPRMKKRDFSLEQLRQYDGSRNPRILLAVNGKVFDVTKGSKFYGPAGPYGIFAGRDASRGLATFCLDKDALRDEYDDLSDLNAVQMESVREWEMQFKEKYDYVGRLLKPGEEPSEYTDEEDTKDHNKQD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
90PhosphorylationGAGAGEESPATSLPR
CCCCCCCCCCCCCCC
18.6119664994
93PhosphorylationAGEESPATSLPRMKK
CCCCCCCCCCCCHHH
33.8930266825
94PhosphorylationGEESPATSLPRMKKR
CCCCCCCCCCCHHHC
38.1822167270
100MalonylationTSLPRMKKRDFSLEQ
CCCCCHHHCCCCHHH
48.1026320211
104PhosphorylationRMKKRDFSLEQLRQY
CHHHCCCCHHHHHHC
34.9723401153
109MethylationDFSLEQLRQYDGSRN
CCCHHHHHHCCCCCC
32.48115487343
114PhosphorylationQLRQYDGSRNPRILL
HHHHCCCCCCCEEEE
26.4519664994
117PhosphorylationQYDGSRNPRILLAVN
HCCCCCCCEEEEEEC
24.47-
118PhosphorylationYDGSRNPRILLAVNG
CCCCCCCEEEEEECC
35.42-
124UbiquitinationPRILLAVNGKVFDVT
CEEEEEECCEEEEEC
38.67-
126AcetylationILLAVNGKVFDVTKG
EEEEECCEEEEECCC
34.23133447
126UbiquitinationILLAVNGKVFDVTKG
EEEEECCEEEEECCC
34.2321890473
1262-HydroxyisobutyrylationILLAVNGKVFDVTKG
EEEEECCEEEEECCC
34.23-
128PhosphorylationLAVNGKVFDVTKGSK
EEECCEEEEECCCCC
7.7224719451
1322-HydroxyisobutyrylationGKVFDVTKGSKFYGP
CEEEEECCCCCCCCC
62.12-
132UbiquitinationGKVFDVTKGSKFYGP
CEEEEECCCCCCCCC
62.12-
133MethylationKVFDVTKGSKFYGPA
EEEEECCCCCCCCCC
27.05-
1352-HydroxyisobutyrylationFDVTKGSKFYGPAGP
EEECCCCCCCCCCCC
51.80-
135AcetylationFDVTKGSKFYGPAGP
EEECCCCCCCCCCCC
51.8025953088
135UbiquitinationFDVTKGSKFYGPAGP
EEECCCCCCCCCCCC
51.8021890473
137PhosphorylationVTKGSKFYGPAGPYG
ECCCCCCCCCCCCCC
26.4128152594
143PhosphorylationFYGPAGPYGIFAGRD
CCCCCCCCCEEECCC
23.1821253578
149MethylationPYGIFAGRDASRGLA
CCCEEECCCCCCCCC
32.65115487335
150UbiquitinationYGIFAGRDASRGLAT
CCEEECCCCCCCCCH
48.2321890473
156UbiquitinationRDASRGLATFCLDKD
CCCCCCCCHHHCCHH
11.0623000965
159UbiquitinationSRGLATFCLDKDALR
CCCCCHHHCCHHHHH
4.1121890473
159GlutathionylationSRGLATFCLDKDALR
CCCCCHHHCCHHHHH
4.1122555962
162AcetylationLATFCLDKDALRDEY
CCHHHCCHHHHHHCC
31.7725825284
162UbiquitinationLATFCLDKDALRDEY
CCHHHCCHHHHHHCC
31.77-
166MethylationCLDKDALRDEYDDLS
HCCHHHHHHCCCCHH
36.11115487327
167PhosphorylationLDKDALRDEYDDLSD
CCHHHHHHCCCCHHH
60.71-
169PhosphorylationKDALRDEYDDLSDLN
HHHHHHCCCCHHHCC
21.0327642862
173MethylationRDEYDDLSDLNAVQM
HHCCCCHHHCCCCHH
47.23-
173PhosphorylationRDEYDDLSDLNAVQM
HHCCCCHHHCCCCHH
47.23-
180SulfoxidationSDLNAVQMESVREWE
HHCCCCHHHHHHHHH
3.1328465586
186AcetylationQMESVREWEMQFKEK
HHHHHHHHHHHHHHH
8.87-
186UbiquitinationQMESVREWEMQFKEK
HHHHHHHHHHHHHHH
8.8723000965
190MethylationVREWEMQFKEKYDYV
HHHHHHHHHHHHCCH
12.16-
191UbiquitinationREWEMQFKEKYDYVG
HHHHHHHHHHHCCHH
36.0821890473
193MalonylationWEMQFKEKYDYVGRL
HHHHHHHHHCCHHCC
43.9726320211
193UbiquitinationWEMQFKEKYDYVGRL
HHHHHHHHHCCHHCC
43.9721890473
193AcetylationWEMQFKEKYDYVGRL
HHHHHHHHHCCHHCC
43.9723749302
193PhosphorylationWEMQFKEKYDYVGRL
HHHHHHHHHCCHHCC
43.97-
1932-HydroxyisobutyrylationWEMQFKEKYDYVGRL
HHHHHHHHHCCHHCC
43.97-
194PhosphorylationEMQFKEKYDYVGRLL
HHHHHHHHCCHHCCC
17.3826074081
196PhosphorylationQFKEKYDYVGRLLKP
HHHHHHCCHHCCCCC
11.1725884760
197PhosphorylationFKEKYDYVGRLLKPG
HHHHHCCHHCCCCCC
3.08-
208PhosphorylationLKPGEEPSEYTDEED
CCCCCCCCCCCCHHH
46.6529255136
210PhosphorylationPGEEPSEYTDEEDTK
CCCCCCCCCCHHHCC
24.6723927012
211PhosphorylationGEEPSEYTDEEDTKD
CCCCCCCCCHHHCCC
32.6529255136
215UbiquitinationSEYTDEEDTKDHNKQ
CCCCCHHHCCCCCCC
57.9421890473
216PhosphorylationEYTDEEDTKDHNKQD
CCCCHHHCCCCCCCC
41.4729255136
217AcetylationYTDEEDTKDHNKQD-
CCCHHHCCCCCCCC-
70.12-
217UbiquitinationYTDEEDTKDHNKQD-
CCCHHHCCCCCCCC-
70.1221890473
220PhosphorylationEEDTKDHNKQD----
HHHCCCCCCCC----
54.54-
226UbiquitinationHNKQD----------
CCCCC----------
-
232Phosphorylation----------------
----------------
20166139
234Phosphorylation------------------
------------------
20166139
235Phosphorylation-------------------
-------------------
18452278
240Phosphorylation------------------------
------------------------
20166139

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of PGRC2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PGRC2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PGRC2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of PGRC2_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PGRC2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND MASSSPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90; SER-208 AND TYR-210,AND MASS SPECTROMETRY.
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography.";
Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.;
Proteomics 8:1346-1361(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-208 AND THR-211, ANDMASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90 AND THR-211, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-211, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-210 AND THR-211, ANDMASS SPECTROMETRY.

TOP